Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Biotech Ingredient Market Expected to Be in 2029?

The market size of the biotech ingredient has shown robust growth in the past few years. It is forecasted to increase from $59.9 billion in 2024 to $63.25 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.6%. The growth in the previous period can be ascribed to new developments in the food and beverage sector, the rising acceptance of biofuel, growing consumer penchant for functional foods, and advances in genetic engineering technology.

In the upcoming years, the biotech ingredient market’s size is projected to witness robust expansion, with an estimated value of $81.66 billion in 2029, which is equivalent to an annual compound growth rate (CAGR) of 6.6%. Factors contributing to this projected growth within the forecast period encompass a focus on personalized nutritional regimes, heightened production of cell-based meat, and advancements in therapeutic biotech ingredients. Other influencing elements might include the use of bio ingredients for waste management and a shift in preference toward bioplastics. Further trends to look out for within this forecast period include functional foods based on biotech, biotech interventions for circular economic practices, therapeutic biotech ingredients and bio-ingredients applied to clean energy production, alongside a global emphasis on conserving biodiversity.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

What Are The Contributors To Demand In The Biotech Ingredient Market?

The burgeoning need for generic drugs is anticipated to fuel the expansion of the biotech ingredient industry in the future. Generic drugs are intended to mimic the characteristics of previously authorized medicines. Biotech ingredients are incorporated in general medicine, as they are the fundamental means of delivering low-cost, effective methods of creating a variety of active ingredients that closely match the original product, and these usually fall under a wider set of regulations. For example, the Personalized Medicine Coalition, a professional association in the US, reported in 2022, the authorization of 12 fresh personalized medicines made up around 34% of all new therapies, representing a notable surge compared to prior years. As a result, the escalating demand for generic drugs is propelling the biotech ingredient industry’s growth.

What Segmentation Categories Are Included In The Biotech Ingredient Market Analysis?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

What Long-Term Trends Are Likely To Affect The Biotech Ingredient Market?

The rise of technological innovation is a notable trend in the biotech ingredient market. To fortify their standing, primary businesses in this industry are using novel technologies to create inventive products. Take for example, the case of International Flavors & Fragrances Inc., a manufacturer hailing from the U.S. that focuses on fragrance, biotech solutions, cosmetic energetics, and organic health ingredients. In March 2023, they introduced Aurist AGC, an innovative biopolymer targeted at hair care, demonstrating the potential of their new DEB platform. This platform leverages IFF’s extensive biotechnological capabilities to offer sustainable and high-performing glamour solutions, contributing towards transformation in the cosmeceutical sector. IFF’s proprietary Designed Enzymatic Biopolymers (DEB) technology, a cutting-edge biotechnology, enables the production of unique biobased polysaccharides with distinct structures and characteristics.

Who Are The Top-Ranked Companies In The Biotech Ingredient Market Today?

Major companies operating in the biotech ingredient market include Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

How Is Biotech Ingredient Market Adoption Varying Across Different Regions And Sectors?

Europe was the largest region in the biotech ingredient market in 2024. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9817&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model